GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity

Cell Reports

Volumn 16, Issue 10, 2016, Pages 2686-2698

  Brackley, Allison Doyle ^a   Gomez, Ruben ^b   Akopian, Armen N ^b   Henry, Michael A ^b   Jeske, Nathaniel A ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CALCIUM; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; NALTRINDOLE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN KINASE C; VOLTAGE GATED CALCIUM CHANNEL; GUANINE NUCLEOTIDE BINDING PROTEIN; NARCOTIC ANALGESIC AGENT; PHOSPHOLIPASE C; RAF KINASE INHIBITORY PROTEIN, RAT;

ANALGESIA; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE; CHANNEL GATING; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; RECEPTOR BINDING; SENSORY NERVE CELL; ANIMAL; DRUG EFFECTS; MALE; METABOLISM; NOCICEPTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; BRADYKININ; G-PROTEIN-COUPLED RECEPTOR KINASE 2; GTP-BINDING PROTEINS; MALE; NOCICEPTION; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN KINASE C; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SENSORY RECEPTOR CELLS; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 85006341764     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.07.084     Document Type: Article

References (55)

1. Alves, I.D., Ciano, K.A., Boguslavski, V., Varga, E., Salamon, Z., Yamamura, H.I., Hruby, V.J., Tollin, G., Selectivity, cooperativity, and reciprocity in the interactions between the delta-opioid receptor, its ligands, and G-proteins. J. Biol. Chem. 279 (2004), 44673–44682.
2. Bradbury, F.A., Zelnik, J.C., Traynor, J.R., G protein independent phosphorylation and internalization of the delta-opioid receptor. J. Neurochem. 109 (2009), 1526–1535.
3. Calderon, S.N., Rothman, R.B., Porreca, F., Flippen-Anderson, J.L., McNutt, R.W., Xu, H., Smith, L.E., Bilsky, E.J., Davis, P., Rice, K.C., Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J. Med. Chem. 37 (1994), 2125–2128.
4. Cayla, C., Labuz, D., Machelska, H., Bader, M., Schäfer, M., Stein, C., Impaired nociception and peripheral opioid antinociception in mice lacking both kinin B1 and B2 receptors. Anesthesiology 116 (2012), 448–457.
5. Cesare, P., Dekker, L.V., Sardini, A., Parker, P.J., McNaughton, P.A., Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 23 (1999), 617–624.
6. Chuang, T.T., LeVine, H. 3rd, De Blasi, A., Phosphorylation and activation of beta-adrenergic receptor kinase by protein kinase C. J. Biol. Chem. 270 (1995), 18660–18665.
7. Cong, M., Perry, S.J., Lin, F.T., Fraser, I.D., Hu, L.A., Chen, W., Pitcher, J.A., Scott, J.D., Lefkowitz, R.J., Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J. Biol. Chem. 276 (2001), 15192–15199.
8. Corbit, K.C., Trakul, N., Eves, E.M., Diaz, B., Marshall, M., Rosner, M.R., Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278 (2003), 13061–13068.
9. Deiss, K., Kisker, C., Lohse, M.J., Lorenz, K., Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2. J. Biol. Chem. 287 (2012), 23407–23417.
10. Delmas, P., Wanaverbecq, N., Abogadie, F.C., Mistry, M., Brown, D.A., Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons. Neuron 34 (2002), 209–220.
11. Dicker, F., Quitterer, U., Winstel, R., Honold, K., Lohse, M.J., Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases. Proc. Natl. Acad. Sci. USA 96 (1999), 5476–5481.
12. Eijkelkamp, N., Wang, H., Garza-Carbajal, A., Willemen, H.L., Zwartkruis, F.J., Wood, J.N., Dantzer, R., Kelley, K.W., Heijnen, C.J., Kavelaars, A., Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK. J. Neurosci. 30 (2010), 12806–12815.
13. Fenalti, G., Giguere, P.M., Katritch, V., Huang, X.P., Thompson, A.A., Cherezov, V., Roth, B.L., Stevens, R.C., Molecular control of δ-opioid receptor signalling. Nature 506 (2014), 191–196.
14. Ferrari, L.F., Bogen, O., Alessandri-Haber, N., Levine, E., Gear, R.W., Levine, J.D., Transient decrease in nociceptor GRK2 expression produces long-term enhancement in inflammatory pain. Neuroscience 222 (2012), 392–403.
15. Ford, C.E., Skiba, N.P., Bae, H., Daaka, Y., Reuveny, E., Shekter, L.R., Rosal, R., Weng, G., Yang, C.S., Iyengar, R., et al. Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280 (1998), 1271–1274.
16. Fu, T., Okano, Y., Hagiwara, M., Hidaka, H., Nozawa, Y., Bradykinin-induced translocation of protein kinases C in neuroblastoma NCB-20 cell: dependence on 1,2-diacylglycerol content and free calcium. Biochem. Biophys. Res. Commun. 162 (1989), 1279–1286.
17. Gavériaux-Ruff, C., Karchewski, L.A., Hever, X., Matifas, A., Kieffer, B.L., Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur. J. Neurosci. 27 (2008), 2558–2567.
18. Georganta, E.M., Agalou, A., Georgoussi, Z., Multi-component signaling complexes of the delta-opioid receptor with STAT5B and G proteins. Neuropharmacology 59 (2010), 139–148.
19. Graness, A., Adomeit, A., Ludwig, B., Müller, W.D., Kaufmann, R., Liebmann, C., Novel bradykinin signalling events in PC-12 cells: stimulation of the cAMP pathway leads to cAMP-mediated translocation of protein kinase Cepsilon. Biochem. J. 327 (1997), 147–154.
20. Guo, J., Wu, Y., Zhang, W., Zhao, J., Devi, L.A., Pei, G., Ma, L., Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated delta-opioid receptor phosphorylation. Mol. Pharmacol. 58 (2000), 1050–1056.
21. Herlitze, S., Garcia, D.E., Mackie, K., Hille, B., Scheuer, T., Catterall, W.A., Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature 380 (1996), 258–262.
22. Hong, M.H., Xu, C., Wang, Y.J., Ji, J.L., Tao, Y.M., Xu, X.J., Chen, J., Xie, X., Chi, Z.Q., Liu, J.G., Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization. J. Neurochem. 108 (2009), 102–114.
23. Khasabova, I.A., Simone, D.A., Seybold, V.S., Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience 115 (2002), 613–625.
24. Khasabova, I.A., Harding-Rose, C., Simone, D.A., Seybold, V.S., Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J. Neurosci. 24 (2004), 1744–1753.
25. Kong, G., Penn, R., Benovic, J.L., A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. J. Biol. Chem. 269 (1994), 13084–13087.
26. Kouhen, O.M., Wang, G., Solberg, J., Erickson, L.J., Law, P.Y., Loh, H.H., Hierarchical phosphorylation of delta-opioid receptor regulates agonist-induced receptor desensitization and internalization. J. Biol. Chem. 275 (2000), 36659–36664.
27. Kroslak, T., Koch, T., Kahl, E., Höllt, V., Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling. J. Biol. Chem. 276 (2001), 39772–39778.
28. Law, P.Y., Bergsbaken, C., Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. J. Pharmacol. Exp. Ther. 272 (1995), 322–332.
29. Lembo, P.M., Ghahremani, M.H., Albert, P.R., Receptor selectivity of the cloned opossum G protein-coupled receptor kinase 2 (GRK2) in intact opossum kidney cells: role in desensitization of endogenous alpha2C-adrenergic but not serotonin 1B receptors. Mol. Endocrinol. 13 (1999), 138–147.
30. Levy, D., Zochodne, D.W., Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain 86 (2000), 265–271.
31. Liebmann, C., Böhmer, F.D., Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling. Curr. Med. Chem. 7 (2000), 911–943.
32. Lorenz, K., Lohse, M.J., Quitterer, U., Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426 (2003), 574–579.
33. Marie, N., Aguila, B., Hasbi, A., Davis, A., Jauzac, P., Allouche, S., Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists. Cell. Signal. 20 (2008), 1209–1220.
34. Namkung, Y., Dipace, C., Urizar, E., Javitch, J.A., Sibley, D.R., G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation. J. Biol. Chem. 284 (2009), 34103–34115.
35. Patwardhan, A.M., Berg, K.A., Akopain, A.N., Jeske, N.A., Gamper, N., Clarke, W.P., Hargreaves, K.M., Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J. Neurosci. 25 (2005), 8825–8832.
36. Patwardhan, A.M., Diogenes, A., Berg, K.A., Fehrenbacher, J.C., Clarke, W.P., Akopian, A.N., Hargreaves, K.M., PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 125 (2006), 114–124.
37. Petcu, M., Dias, J.P., Ongali, B., Thibault, G., Neugebauer, W., Couture, R., Role of kinin B1 and B2 receptors in a rat model of neuropathic pain. Int. Immunopharmacol. 8 (2008), 188–196.
38. Pettinger, L., Gigout, S., Linley, J.E., Gamper, N., Bradykinin controls pool size of sensory neurons expressing functional δ-opioid receptors. J. Neurosci. 33 (2013), 10762–10771.
39. Pradhan, A.A., Becker, J.A., Scherrer, G., Tryoen-Toth, P., Filliol, D., Matifas, A., Massotte, D., Gavériaux-Ruff, C., Kieffer, B.L., In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS ONE, 4, 2009, e5425.
40. Pradhan, A., Smith, M., McGuire, B., Evans, C., Walwyn, W., Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels. Mol. Pain, 9, 2013, 8.
41. Premont, R.T., Inglese, J., Lefkowitz, R.J., Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9 (1995), 175–182.
42. Pronin, A.N., Benovic, J.L., Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C. J. Biol. Chem. 272 (1997), 3806–3812.
43. Reiter, E., Marion, S., Robert, F., Troispoux, C., Boulay, F., Guillou, F., Crepieux, P., Kinase-inactive G-protein-coupled receptor kinases are able to attenuate follicle-stimulating hormone-induced signaling. Biochem. Biophys. Res. Commun. 282 (2001), 71–78.
44. Rodbell, M., Birnbaumer, L., Pohl, S.L., Krans, H.M., The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J. Biol. Chem. 246 (1971), 1877–1882.
45. Rowan, M.P., Ruparel, N.B., Patwardhan, A.M., Berg, K.A., Clarke, W.P., Hargreaves, K.M., Peripheral delta opioid receptors require priming for functional competence in vivo. Eur. J. Pharmacol. 602 (2009), 283–287.
46. Rowan, M.P., Szteyn, K., Doyle, A.P., Gomez, R., Henry, M.A., Jeske, N.A., β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons. Mol. Pain, 10, 2014, 50.
47. Stein, C., Zöllner, C., Opioids and sensory nerves. Handbook Exp. Pharmacol. 194 (2009), 495–518.
48. Stein, C., Millan, M.J., Shippenberg, T.S., Peter, K., Herz, A., Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 248 (1989), 1269–1275.
49. Steranka, L.R., Manning, D.C., DeHaas, C.J., Ferkany, J.W., Borosky, S.A., Connor, J.R., Vavrek, R.J., Stewart, J.M., Snyder, S.H., Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. USA 85 (1988), 3245–3249.
50. Sugiura, T., Tominaga, M., Katsuya, H., Mizumura, K., Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J. Neurophysiol. 88 (2002), 544–548.
51. Sullivan, L.C., Berg, K.A., Clarke, W.P., Dual regulation of δ-opioid receptor function by arachidonic acid metabolites in rat peripheral sensory neurons. J. Pharmacol. Exp. Ther. 353 (2015), 44–51.
52. Tippmer, S., Quitterer, U., Kolm, V., Faussner, A., Roscher, A., Mosthaf, L., Müller-Esterl, W., Häring, H., Bradykinin induces translocation of the protein kinase C isoforms alpha, epsilon, and zeta. Eur. J. Biochem. 225 (1994), 297–304.
53. Vanderah, T.W., Delta and kappa opioid receptors as suitable drug targets for pain. Clin. J. Pain 26:Suppl 10 (2010), S10–S15.
54. Wang, S., Dai, Y., Fukuoka, T., Yamanaka, H., Kobayashi, K., Obata, K., Cui, X., Tominaga, M., Noguchi, K., Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain. Brain 131 (2008), 1241–1251.
55. Xu, C., Hong, M.H., Zhang, L.S., Hou, Y.Y., Wang, Y.H., Wang, F.F., Chen, Y.J., Xu, X.J., Chen, J., Xie, X., et al. Serine 363 of the delta-opioid receptor is crucial for adopting distinct pathways to activate ERK1/2 in response to stimulation with different ligands. J. Cell Sci. 123 (2010), 4259–4270.